Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04706481

Archival of Human Biological Samples in CU-Med Biobank

CU-Med Biobank collaborates with different researchers for collecting and distributing human biospecimens and clinical data for assisting scientific research.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Healthy Cancer Cardiovascular Diseases Diabetes Diabetes Mellitus Disease Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Heart Diseases Kidney Diseases Male Urogenital Diseases Metabolic Diseases Neoplasms Neurological Diseases or Conditions Nutritional and Metabolic Diseases Other Disease Pathologic Processes Pathological Conditions, Signs and Symptoms Urogenital Diseases Urologic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

CU-Med Biobank will collect and store high-quality specimens from cancer-related or other diseases. All samples are linked to annotated clinical data from approved consented protocols. This system provides researchers with high- quality biological samples and comprehensive clinical, pathological including molecular/genetic information for their research. This standardized CU-Med Biobank is a pivotal bridge to improve the translation of basic research into clinical applications. These findings will contribute to improve prevention, enhance diagnosis, develop new treatment and eventual cure of diseases.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Enrolled subjects that have provided signed consent for the specimens and de-identified data to be collected, stored and distributed.

Exclusion criteria

  • Subjects without signed informed consent for the specimens and de-identified data to be collected, stored and distributed.

Treatment and study plan

Specimen Collection

Procedure

Specimens obtained from surgical, phlebotomy or other non-invasive procedure

Primary outcomes

  1. To distribute human biospecimens for clinical research

    Time frame: 99 years

    By using the biological samples from CU-Med Biobank, translational studies can be done.

  2. To discover the pathological mechanism of different acute and chronic diseases such as cancer, stroke, heart disease, dementia & diabetes

    Time frame: 99 years

    The relationship between different genome/proteome/bacteriome/virome and various diseases can be revealed, thus leading to a better prognostic and diagnostic outcome.

Study contacts

Contact information is provided by the study sponsor or research team.

Marcus LAW, M. Phil

CONTACT

[email protected]

852-26285221

Terry OR, Ph.D

CONTACT

[email protected]

852-26285221

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Important dates

Study start
2020
Primary completion
2050
Study completion
2050
First posted
Jan 12, 2021
Registry last updated
Mar 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.